Literature DB >> 21414406

ERRs and cancers: effects on metabolism and on proliferation and migration capacities.

Stéphanie Bianco1, Juliette Sailland, Jean-Marc Vanacker.   

Abstract

ERRs are orphan members of the nuclear receptor superfamily which, at least for ERRα and ERRγ display important roles in the control of various metabolic processes. On other hand, correlations have been found between the expression of ERRα and γ and diverse parameters of tumor progression in human cancers. Whereas it is tempting to speculate that ERR receptors act in tumors through the regulation of metabolism, recent data have suggested that they also may directly regulate tumor proliferation and progression independently of their effects on metabolism. The two aspects of tumoral functions of ERR receptors are the purpose of the present review.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21414406     DOI: 10.1016/j.jsbmb.2011.03.014

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  24 in total

1.  ERK/MAPK regulates ERRγ expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer.

Authors:  Mary M Heckler; Hemang Thakor; Cara C Schafer; Rebecca B Riggins
Journal:  FEBS J       Date:  2014-04-28       Impact factor: 5.542

2.  The pERK of being a target: Kinase regulation of the orphan nuclear receptor ERRγ.

Authors:  Rebecca B Riggins
Journal:  Receptors Clin Investig       Date:  2014

Review 3.  Minireview: nuclear receptor coregulators of the p160 family: insights into inflammation and metabolism.

Authors:  David A Rollins; Maddalena Coppo; Inez Rogatsky
Journal:  Mol Endocrinol       Date:  2015-02-03

4.  ERRα induces H3K9 demethylation by LSD1 to promote cell invasion.

Authors:  Julie Carnesecchi; Christelle Forcet; Ling Zhang; Violaine Tribollet; Bruno Barenton; Rafik Boudra; Catherine Cerutti; Isabelle M L Billas; Aurélien A Sérandour; Jason S Carroll; Claude Beaudoin; Jean-Marc Vanacker
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-27       Impact factor: 11.205

5.  The PLA2R1-JAK2 pathway upregulates ERRα and its mitochondrial program to exert tumor-suppressive action.

Authors:  A Griveau; G Devailly; L Eberst; N Navaratnam; B Le Calvé; M Ferrand; P Faull; A Augert; R Dante; J M Vanacker; D Vindrieux; D Bernard
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

Review 6.  The estrogen-related receptors (ERRs): potential targets against bone loss.

Authors:  Ling Zhang; Jiemin Wong; Jean-Marc Vanacker
Journal:  Cell Mol Life Sci       Date:  2016-08-11       Impact factor: 9.261

7.  High expression of estrogen-related receptor α is significantly associated with poor prognosis in patients with colorectal cancer.

Authors:  Rong Liang; Yan Lin; Chun-Ling Yuan; Zhi-Hui Liu; Yong-Qiang Li; Xiao-Ling Luo; Jia-Zhou Ye; Hai-Hong Ye
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

8.  Effects of estrogen-related receptor alpha (ERRα) on proliferation and metastasis of human lung cancer A549 cells.

Authors:  Jian-Wei Huang; Bao-Zhang Guan; Liang-Hong Yin; Fan-Na Liu; Bo Hu; Qi-Yi Zheng; Fo-Lan Li; Ying-Xue Zhong; Yu Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-12-06

9.  Estrogen-related receptor α in normal adrenal cortex and adrenocortical tumors: involvement in development and oncogenesis.

Authors:  Saulo J A Felizola; Yasuhiro Nakamura; Xiao-Gang Hui; Fumitoshi Satoh; Ryo Morimoto; Keely M McNamara; Sanae Midorikawa; Shinichi Suzuki; William E Rainey; Hironobu Sasano
Journal:  Mol Cell Endocrinol       Date:  2012-10-30       Impact factor: 4.102

10.  Estrogen-related receptor α decreases RHOA stability to induce orientated cell migration.

Authors:  Juliette Sailland; Violaine Tribollet; Christelle Forcet; Cyrielle Billon; Bruno Barenton; Julie Carnesecchi; Alice Bachmann; Karine Cécile Gauthier; Shan Yu; Vincent Giguère; Franky L Chan; Jean-Marc Vanacker
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.